SkyePharma Aktie

SkyePharma für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN DE: 915567 / ISIN: US8308081012

<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
03.09.2024 13:25:27

Skye Bioscience Appoints Puneet Arora As New Chief Medical Officer

(RTTNews) - Biopharmaceutical company Skye Bioscience, Inc. (SKYE) announced Tuesday the appointment of Puneet Arora as Chief Medical Officer (CMO).

Arora is a board-certified physician in endocrinology, diabetes and metabolism. His career includes serving as a physician-scientist, drug developer and executive leader with more than 15 years of experience in designing and executing all phases of clinical trials across multiple therapeutic areas, regulatory submissions, and medical affairs in addition to fundraising with small biotech and large pharma.

Arora was CMO at Lassen Therapeutics. He joined Lassen at the preclinical stage. He previously served as Head of Clinical Development at Principia Biopharma, a Sanofi company. He also served as Senior Medical Director, Early Clinical Development and Clinical Team Leader, Inflammation/Cardiovascular-Metabolism, at Genentech Research and Early Development.

Nachrichten zu SkyePharma plc (Spons. ADRS)mehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu SkyePharma plc (Spons. ADRS)mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!